Literature DB >> 16243315

Inhibition of RhoA-mediated SRF activation by p116Rip.

Jacqueline Mulder1, Aafke Ariaens, Francis P G van Horck, Wouter H Moolenaar.   

Abstract

p116Rip, originally identified as a binding partner of activated RhoA, is an actin-binding protein that interacts with the regulatory myosin-binding subunit (MBS) of myosin-II phosphatase and is essential for Rho-regulated cytoskeletal contractility. Here, we have examined the role of p116Rip in RhoA-mediated activation of the transcription factor SRF. We show that p116Rip oligomerizes via its C-terminal coiled-coil domain and, when overexpressed, inhibits RhoA-induced SRF activation without affecting RhoA-GTP levels. Mutant forms of p116Rip that fail to oligomerize or bind to MBS are still capable of inhibiting SRF activity. Our results suggest that p116Rip interferes with RhoA-mediated transcription through its ability to disassemble the actomyosin cytoskeleton downstream of RhoA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243315     DOI: 10.1016/j.febslet.2005.09.083

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Reactive oxygen species-dependent RhoA activation mediates collagen synthesis in hyperoxic lung fibrosis.

Authors:  Dmitry Kondrikov; Ruth B Caldwell; Zheng Dong; Yunchao Su
Journal:  Free Radic Biol Med       Date:  2011-03-23       Impact factor: 7.376

Review 2.  Myosin phosphatase target subunit: Many roles in cell function.

Authors:  Fumio Matsumura; David J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

3.  Myozap, a novel intercalated disc protein, activates serum response factor-dependent signaling and is required to maintain cardiac function in vivo.

Authors:  Thalia S Seeger; Derk Frank; Claudia Rohr; Rainer Will; Steffen Just; Christine Grund; Robert Lyon; Mark Luedde; Manfred Koegl; Farah Sheikh; Wolfgang Rottbauer; Werner W Franke; Hugo A Katus; Eric N Olson; Norbert Frey
Journal:  Circ Res       Date:  2010-01-21       Impact factor: 17.367

4.  Inhibition of MLC20 phosphorylation downstream of Ca2+ and RhoA: A novel mechanism involving phosphorylation of myosin phosphatase interacting protein (M-RIP) by PKG and stimulation of MLC phosphatase activity.

Authors:  Sunila Mahavadi; Ancydimpy Nalli; Othman Al-Shboul; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-01       Impact factor: 2.194

5.  miR-210 expression is associated with methionine-induced differentiation of trout satellite cells.

Authors:  Mary Latimer; Nathalie Sabin; Aurélie Le Cam; Iban Seiliez; Peggy Biga; Jean-Charles Gabillard
Journal:  J Exp Biol       Date:  2017-06-02       Impact factor: 3.312

Review 6.  Phosphorylation of the regulatory light chain of myosin in striated muscle: methodological perspectives.

Authors:  Haiyang Yu; Samya Chakravorty; Weihua Song; Michael A Ferenczi
Journal:  Eur Biophys J       Date:  2016-04-15       Impact factor: 1.733

7.  The F-Actin-Binding MPRIP Forms Phase-Separated Condensates and Associates with PI(4,5)P2 and Active RNA Polymerase II in the Cell Nucleus.

Authors:  Can Balaban; Martin Sztacho; Michaela Blažíková; Pavel Hozák
Journal:  Cells       Date:  2021-04-08       Impact factor: 6.600

8.  Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.

Authors:  Gwennan André; Juan E Sandoval; Kevin Retailleau; Laurent Loufrani; Gilles Toumaniantz; Stefan Offermanns; Malvyne Rolli-Derkinderen; Gervaise Loirand; Vincent Sauzeau
Journal:  J Am Heart Assoc       Date:  2014-06-17       Impact factor: 5.501

9.  Interaction of Myosin Phosphatase Target Subunit (MYPT1) with Myosin Phosphatase-RhoA Interacting Protein (MRIP): A Role of Glutamic Acids in the Interaction.

Authors:  Eunhee Lee; Walter F Stafford
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

10.  Activation of the Sphingosine 1 Phosphate-Rho Pathway in Pterygium and in Ultraviolet-Irradiated Normal Conjunctiva.

Authors:  Nozomi Igarashi; Megumi Honjo; Takashi Fujishiro; Tetsuya Toyono; Takashi Ono; Yosai Mori; Kazunori Miyata; Hideru Obinata; Makoto Aihara
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.